# Delivery Order #15B50527F00000002

Delivery Order for Uptravi Pharmaceutical under VA Federal Supply Schedule

**Buyer:** Federal Prison System / Bureau of Prisons

**Award Amount:** $15,064.44
**Ceiling:** $15,064.44

**Awarded:** October 21, 2026
**Period of Performance:** Oct 21, 2026 - Oct 21, 2026

**Identifier:** 15B50527F00000002
**NAICS:** 325412

This award covers a delivery order contract under an existing Federal Supply Schedule (FSS) indefinite delivery vehicle with Actelion Pharmaceuticals US, Inc., a U.S.-owned pharmaceutical company specializing in hematology-related products. The order procures Uptravi 200mcg in 60-count bottles, a medication intended for medical use within the Department of Veterans Affairs (VA) healthcare system, highlighting the contract's role in providing essential pharmaceutical support to veterans. The contract involves a one-time delivery with a performance date set in late 2026 at a location in Titusville, New Jersey. It is part of a larger, competitively awarded FSS contract, ensuring efficient and timely access to critical medications under full and open competition with no set-aside. There are no key subcontractors or previous contracts linked directly to this delivery order. The parent FSS contract, awarded recently with a substantial multi-year term, covers broad pharmaceutical needs of the VA and enables streamlined procurement processes for veteran care.

### Description

CURASCRIPT, (1)UPTRAVI 200MCG 60 CT BOTTLE OCT FY27

[View original record](https://www.usaspending.gov/award/CONT_AWD_15B50527F00000002_1540_36F79724D0159_3600)
